View Entire Collection
By Clinical Topic
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
WEDNESDAY, April 7 (HealthDay News) -- The U.S. Food and Drug Administration has issued warning letters to six U.S.-based medical spas and a Brazilian company, saying they made false or misleading statements that "lipodissolve" procedures are safe and effective, or otherwise misbranded the products.
Lipodissolve involves drug injections intended to dissolve and remove small pockets of fat. The U.S. companies that received the warning letters have made claims that the drugs they use for lipodissolve procedures are effective and safe. However, the FDA has not evaluated or approved the products for this use.
The drugs most often used for lipodissolve procedures are combinations of phosphatidylcholine and deoxycholate, but sometimes ingredients such as vitamins, minerals and herbal extracts are included in lipodissolve mixtures, according to the FDA. The agency said it is not aware of any credible scientific evidence that supports the effectiveness or safety of lipodissolve for fat elimination.
"We are concerned that these companies are misleading consumers," Janet Woodcock, M.D., director of the FDA's Center for Drug Evaluation and Research, said in a statement. "It is important for anyone who is considering this voluntary procedure to understand that the products used to perform lipodissolve procedures are not approved by the FDA for fat removal."
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top